Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 62.82 percent increase over losses of $(1.56) per share from the same period last year. The company reported quarterly sales of $37.943 million which missed the analyst consensus estimate of $165.540 million by 77.08 percent. This is a 189.75 percent increase over sales of $13.095 million the same period last year.